Concepedia

Author

Keith Gorden

Biota Pharmaceuticals (United States)

Also Known As

K B Gorden, K Gorden, K. Gorden, KEITH GORDEN, Kabir Gorden, Keith B Gorden, Keith B. Gorden, Keith Gorden

43

Publications

1.6K

Citations

11

H-Index

43

Concepts

All Affiliations

Biota Pharmaceuticals (United States)Biothera (United States)University of Minnesota3M (United States)Rutgers, The State University of New Jersey
KG

About

Keith Gorden is an author at Biota Pharmaceuticals (United States) specializing in medicine, innate immunity, and immune regulation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

533

2

Biochemistry

2

2

104

3

Cell Biology

2

2

435

4

Natural Sciences

1

1

44

5

Cellular Physiology

1

1

60

Keith Gorden

×

12

Publications

1.5K

Citations

11

H-Index

YearCitations

Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8

Keith Gorden, Kevin Gorski, Sheila J. Gibson,

The Journal of Immunology

2005

670

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod

Sheila J. Gibson, Jana M. Lindh, Tony R. Riter,

Cellular Immunology

2002

375

Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists

Kevin Gorski, Emily L. Waller, Jacqueline Bjornton-Severson,

International Immunology

2006

155

Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent

Nandita Bose, Anissa Chan, Faimola O. Guerrero,

Frontiers in Immunology

2013

60

The Role of B7 Costimulation by Murine Acute Myeloid Leukemia in the Generation and Function of a CD8+ T-Cell Line With Potent In Vivo Graft-Versus-Leukemia Properties

Michael W. Boyer, Daniel A. Vallera, Patricia A. Taylor,

Blood

1997

58

A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3–1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer

Michael Thomas, Parvis Sadjadian, Jens Kollmeier,

Investigational New Drugs

2017

50

The isocitrate dehydrogenase phosphorylation cycle. Identification of the primary rate-limiting step.

C S Stueland, Keith Gorden, D C LaPorte

Journal of Biological Chemistry

1988

44

Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation

Anissa Chan, Adria Bykowski Jonas, Xiaohong Qiu,

PLoS ONE

2016

40

B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.

Emmanuel Katsanis, Zhiyi Xu, María A. Bausero,

PubMed

1995

18

Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies

Anissa Chan, Takashi Kangas, Xiaohong Qiu,

Frontiers in Oncology

2022

17

Page 1